Remove Antibody Remove Clinical Development Remove Genome Project Remove Pharma Companies
article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

Alchemab, on the other hand, has developed a highly differentiated platform which enables the identification of novel drug targets and therapeutics by analysis of patient antibody repertoires, drawing from the expertise in Cambridge to progress the company’s mission to build a broad pipeline of protective therapeutics for hard-to-treat diseases.

Drugs 75